Current Report Filing (8-k)
April 30 2019 - 12:48PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 30, 2019 (April 26, 2019)
FUSE MEDICAL, INC.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-10093
|
|
59-1224913
|
(State or other jurisdiction of
incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
1565 North Central Expressway
Suite 220
Richardson,
Texas
|
|
75080
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants Telephone Number, including area code: (469) 862-3030
(Former name, former address and former fiscal year, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2.):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01
|
Entry into a Material Definitive Agreement
|
On April 26, 2019, Fuse Medical, Inc., a Delaware corporation (the
Company
), the Companys wholly-owned subsidiary, CPM Medical
Consultants, LLC (together with the Company, the
Borrowers
), and Zions Bancorporation, N.A. dba Amegy Bank (the
Lender
) executed that certain letter agreement, dated April 26, 2019, in the form attached
hereto as
Exhibit 10.1
(the
Waiver Agreement
), pursuant to which Lender waived an event of default by Borrowers (an
Event of Default
) under that certain Amended and Restated Business Loan Agreement among
Borrowers and the Lender, dated December 31, 2017 (as amended, the
Loan Agreement
), as reported in Item 2.03 of the Companys Current Report on Form 8-K filed with the Securities and Exchange Commission on
January 11, 2018.
Pursuant to the Waiver Agreement, the Lender waived the Event of Default arising from non-compliance with the requirement to have
a minimum EBITDA of $100,000 for the period ending March 31, 2019. Under the terms of the Waiver Agreement, the Lender and Borrower have agreed to proceed in good faith to execute an amendment to the Loan Agreement by May 15, 2019.
The foregoing description of the Waiver Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Waiver
Agreement, which is filed herewith as
Exhibit 10.1
, and incorporated herein by reference.
Item 2.04
|
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an
Off-Balance Sheet Arrangement.
|
The information set forth under
Item 1.01
is incorporated herein by reference.
Item 9.01.
|
Financial Statements and Exhibits.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
|
|
|
FUSE MEDICAL, INC.
|
|
|
By:
|
|
/s/ William E. McLaughlin, III
|
|
|
William E. McLaughlin, III
Senior Vice
President,
Chief Financial Officer and Director
|
Date:
April 30, 2019
Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Sep 2023 to Sep 2024